Literature DB >> 9971839

Group D adenoviruses infect primary central nervous system cells more efficiently than those from group C.

M Chillon1, A Bosch, J Zabner, L Law, D Armentano, M J Welsh, B L Davidson.   

Abstract

Group C adenovirus-mediated gene transfer to central nervous system cells is inefficient. We found that wild-type group D viruses, or recombinant adenovirus type 2 (Ad2) (group C) modified to contain Ad17 (group D) fiber, were more efficient in infecting primary cultures of neurons. Together with studies on primary vascular endothelial cells and tissue culture cell lines, our results indicate that there is not a universally applicable adenovirus serotype for use as a gene transfer vector.

Entities:  

Mesh:

Year:  1999        PMID: 9971839      PMCID: PMC104501     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment.

Authors:  T J Wickham; P Mathias; D A Cheresh; G R Nemerow
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

2.  A model system for in vivo gene transfer into the central nervous system using an adenoviral vector.

Authors:  B L Davidson; E D Allen; K F Kozarsky; J M Wilson; B J Roessler
Journal:  Nat Genet       Date:  1993-03       Impact factor: 38.330

3.  Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain.

Authors:  S C Stevenson; M Rollence; B White; L Weaver; A McClelland
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

4.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.

Authors:  J Gall; A Kass-Eisler; L Leinwand; E Falck-Pedersen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis.

Authors:  D P Rich; L A Couture; L M Cardoza; V M Guiggio; D Armentano; P C Espino; K Hehir; M J Welsh; A E Smith; R J Gregory
Journal:  Hum Gene Ther       Date:  1993-08       Impact factor: 5.695

6.  Stepwise dismantling of adenovirus 2 during entry into cells.

Authors:  U F Greber; M Willetts; P Webster; A Helenius
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

7.  Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer.

Authors:  B L Davidson; S E Doran; D S Shewach; J M Latta; J W Hartman; B J Roessler
Journal:  Exp Neurol       Date:  1994-02       Impact factor: 5.330

8.  Adenovirus gene transfer causes inflammation in the brain.

Authors:  A P Byrnes; J E Rusby; M J Wood; H M Charlton
Journal:  Neuroscience       Date:  1995-06       Impact factor: 3.590

9.  Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain.

Authors:  A L Betz; G Y Yang; B L Davidson
Journal:  J Cereb Blood Flow Metab       Date:  1995-07       Impact factor: 6.200

10.  Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization.

Authors:  T J Wickham; E J Filardo; D A Cheresh; G R Nemerow
Journal:  J Cell Biol       Date:  1994-10       Impact factor: 10.539

View more
  13 in total

1.  Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.

Authors:  D M Shayakhmetov; T Papayannopoulou; G Stamatoyannopoulos; A Lieber
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Dependence of adenovirus infectivity on length of the fiber shaft domain.

Authors:  D M Shayakhmetov; A Lieber
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Adenovirus serotype 30 fiber does not mediate transduction via the coxsackie-adenovirus receptor.

Authors:  Lane K Law; Beverly L Davidson
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 4.  Targeting gene therapy vectors to the vascular endothelium.

Authors:  Lorraine M Work; Stuart A Nicklin; Andrew H Baker
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

5.  General strategy for broadening adenovirus tropism.

Authors:  Laura Fontana; Maurizio Nuzzo; Lorena Urbanelli; Paolo Monaci
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Comparative sequence analysis of the largest E1A proteins of human and simian adenoviruses.

Authors:  Nikita Avvakumov; Russ Wheeler; Jean Claude D'Halluin; Joe S Mymryk
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 7.  Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology.

Authors:  Rachel J Sizemore; Sonja Seeger-Armbruster; Stephanie M Hughes; Louise C Parr-Brownlie
Journal:  J Neurophysiol       Date:  2016-02-17       Impact factor: 2.714

Review 8.  Transductional targeting of adenovirus vectors for gene therapy.

Authors:  J N Glasgow; M Everts; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-27       Impact factor: 5.987

9.  Functional and selective targeting of adenovirus to high-affinity Fcgamma receptor I-positive cells by using a bispecific hybrid adapter.

Authors:  C Ebbinghaus; A Al-Jaibaji; E Operschall; A Schöffel; I Peter; U F Greber; S Hemmi
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

10.  Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber.

Authors:  Takafumi Nakamura; Kenzo Sato; Hirofumi Hamada
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.